Filing Details
- Accession Number:
- 0001209191-22-060145
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-07 16:13:38
- Reporting Period:
- 2022-12-05
- Accepted Time:
- 2022-12-07 16:13:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1831097 | Agilon Health Inc. | AGL | Services-Misc Health & Allied Services, Nec (8090) | 371915147 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1855842 | Benjamin Kornitzer | C/O Agilon Health, Inc. 6210 E Hwy 290, Suite 450 Austin TX 78723 | Chief Med. & Quality Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-05 | 5,398 | $4.49 | 15,824 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-05 | 5,398 | $17.80 | 10,426 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-12-06 | 5,398 | $4.49 | 15,824 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-06 | 5,398 | $17.72 | 10,426 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options (Rights to Buy) | Disposition | 2022-12-05 | 5,398 | $0.00 | 5,398 | $4.49 |
| Common Stock | Options (Rights to Buy) | Disposition | 2022-12-06 | 5,398 | $0.00 | 5,398 | $4.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 290,307 | 2030-01-31 | No | 4 | M | Direct | |
| 284,909 | 2030-01-31 | No | 4 | M | Direct |
Footnotes
- Includes restricted stock units.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.72 to $17.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.69 to $17.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024.
Billionaire Hedge Funds
